Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Job Security in a Changing Biopharma Environment

December 1, 2012

Results from the 2012 employment survey.

Stability in Biopharmaceutical Storage

November 1, 2012

Patrick Jackson of Vindon Scientific offers key considerations for choosing an outsourced sample storage facility.

Recent Therapeutics IPOs Outshine Market, but Performance Mixed for Broader Life-Sciences Issues

October 1, 2012

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Streamlining Batch Record Review and Approval

August 1, 2012

A one-day sign off for batch records is considered a best practice in the industry.

Compressing Drug Development Timelines with Accelerated Immunoassay

August 1, 2012

Recently developed immunoassay technology platforms reduce sample volume requirements and improve cycle times.

Pharmaceutical Dealmaking Broadens its Partnering Base

July 1, 2012

Collaborative R&D models coincide with new ways to fund translational research.

Using a Systematic Approach to Select Critical Process Parameters

July 1, 2012

Harmonized regulations call for a risk-based and systematic approach to evaluating and selecting CPPs.

A 25-Year Retrospective on Bio-Engineering

July 1, 2012

Steven S. Kuwahara, PhD, principal consultant at GXP BioTechnology LLC, gives an update on "Engineering the Cell-System Interface."

25 Years of Biopharmaceutical Innovation: An Expert Roundtable

June 1, 2012

Industry experts discuss significant achievements. Plus: What's in store for the future.



Click here